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Abstract Background The aim of this study was to evaluate the association between red blood
cell (RBC) transfusions on the risk of death, retinopathy of prematurity (ROP),
bronchopulmonary dysplasia (BPD), and necrotizing enterocolitis (NEC) in very low
birth weight (VLBW) infants.
Study Design and Methods This is an observational study. Data were entered
prospectively into the study database at the time of the ﬁrst transfusion. Clinical
characteristics, adverse events, and outcomes of the patients transfused in the ﬁrst
28 days of life were compared with the population of VLBW infants not transfused
during the same period. The association among birth weight, gestational age,
comorbidities, and the number of transfusions was estimated with a Poisson regression
model. The association between the composite outcome and the occurrence of death,
ROP, or BPD separately considered and a set of covariates was estimated with a logistic
regression model.
Results We enrolled 641 VLBW infants, 42% of whom were transfused. Transfusions
were associated with the risk of developing the composite outcome, independently
from other conditions; this risk correlated with several transfusions  3 (odds ratio:
5.88, 95% conﬁdence interval: 2.74–12.6). ROP and BPD were associated with several
transfusions  3.
Conclusion We observed an association between RBC transfusions and the composite
risk of death or ROP, BPD, and NEC.
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Red blood cell (RBC) transfusion is an important supportive
therapy in the neonatal period. Nearly 40% of preterm new-
bornswith birthweight (BW)between1,000 and 1,500 g (very
low BW [VLBW]) and more than 90% weighing less than
1,000 g (extremely low BW [ELBW]) receive at least one blood
transfusion during their hospital stay.1–4 The most common
rationale for transfusing packed RBC in preterm infants is to
improve oxygen delivery. Many neonatal intensive care units
(NICUs) adopt transfusion guidelines based on hemoglobin or
hematocrit levels combined with clinical conditions, days of
life, and the need for respiratory or oxygen supports. However,
no biochemical or instrumental tests have identiﬁed a target
hemoglobin or hematocrit below which an RBC transfusion
can deﬁnitely provide beneﬁts to premature newborns.2,3,5–13
Furthermore, there is a growing body of evidences that RBC
transfusions could be harmful. Studies in adult and pediatric
patients found a signiﬁcant association between RBC transfu-
sion and increasedmortality or morbidity.14–19 In the past few
years, evidence for a negative effect of RBC transfusions was
also reported in neonatal clinical practices. dos Santos et al
observed that RBC transfusions in VLBW infants were associ-
ated with higher risk of death20 and many observational
studies suggest a temporal relationship between RBC transfu-
sion and the development of necrotizing enterocolitis (NEC)
and germinal matrix hemorrhage–intraventricular hemor-
rhage (GMH-IVH) in VLBW infants.21–29 Various hypotheses
have been advocated for these associations, but none of them
has yet been conﬁrmed. The introductionof gamma irradiation
and leukocyte reduction from RBC before storage was demon-
strated to reduce the incidence of retinopathy of prematurity
(ROP) and bronchopulmonary dysplasia (BPD) in newborns
weighing less than 1,250 g.30 The use of RBC units with a short
period of storage has been associated with lower morbidity
and mortality in adult and pediatric patients,31–33 but these
advantageswere not conﬁrmed in premature newborns.34 The
cause-and-effect relationship of RBC transfusion with adverse
clinical outcomes is difﬁcult to establish due to numerous
multiple confounding factors. Two randomized trials2,12 did
not ﬁnd differences in death, ROP, BPD, or NEC between
patients transfused with different transfusion threshold; vari-
ous observational trials in premature and VLBW in-
fants14–19,34–36 suggested a worsening of short- and long-
term prognoses in the most transfused infants, but deﬁnitive
conclusions have yet to be drawn. Our study investigates the
hypothesis that RBC transfusions are associated with an in-
creased risk of death or the development of NEC, ROP, and BPD
in a large cohort of VLBW infants.
Materials and Methods
Inclusion criteria: This single-center longitudinal study
enrolled all infants with BW  1,500 g born between Janu-
ary 2007 and December 2012 at our institution or outborn
admitted to our NICUwithin 6 hours of life. Exclusion criteria:
Infants with major congenital anomalies, chromosomal
defects, metabolic diseases, congenital heart disease, born
from human immunodeﬁciency virus-positive mothers, and
dead in the ﬁrst 24 hours of life were excluded.
Data Collection and Deﬁnitions
Neonates included in the study underwent transfusion ac-
cording to our institutional transfusion guidelines in force
since 2006 and unchanged during the study period
(►Table 1). Data collected from electronic medical records
were entered prospectively into the study database at the
time of the ﬁrst transfusion and updated after every RBC
transfusion. Data of not transfused VLBW admitted to our
NICU during the same time lapse were collected retrospec-
tively at the end of each year. Clinical characteristics, adverse
events, and outcomes of the VLBW infants transfused in the
ﬁrst 28 days of life were compared with the population of
VLBW not transfused during the same time lapse. We ana-
lyzed the following neonatal characteristics: gestational age
(GA); BW; Apgar score at 1 and 5 minutes of life; small for GA
(SGA) deﬁned as a BW < 10th percentile for GA, need for
intubation in the delivery room, twins and multiples, days of
mechanical ventilation (when more than 5 days), pharmaco-
logical treatment of patent ductus arteriosus (ibuprofen or
indomethacin), each pretransfusion hemoglobin (g/dL) in the
ﬁrst 28 days of life, need for major surgery during the ﬁrst
28 days of life, any grade of GMH-IVH detected by cranial
ultrasound, sepsis (deﬁned by positive blood culture), dura-
tion of hospitalization, death or the presence of ROP, BPD, and
NEC. Sepsis, intraventricular hemorrhage (IVH) 3 and 4
degrees grade, mechanical ventilation > 5 days, intubation
in the delivery room, and major surgery in the ﬁrst 14 days
were considered the most signiﬁcant risk factors associated
with a higher RBC transfusion rate and were aggregated in a
single variable. ROP was diagnosed according to the Interna-
tional Classiﬁcation of ROP; we recorded only cases of ROP
grade  2. BPD was deﬁned according to the criteria pro-
posed by Jobe and Bancalari at 36 weeks corrected age.37 NEC
was diagnosed on the basis of clinical and radiographic
ﬁndings according to the modiﬁed Bell’s staging criteria.
During the study period, feeding was not interrupted during
Table 1 Institutional guidelines for RBC transfusion in VLBW
infants
Mechanical ventilation or noninvasive ventilation
requiring FiO2 > 0.4: consider RBC transfusion if
hematocrit < 40%
Spontaneous breathing
Age < 15 d: consider RBC transfusion if hematocrit < 35%
Age 15–28 d: consider RBC transfusion if
hematocrit < 30%
Age > 28 d: consider RBC transfusion if hematocrit < 25%
and reticulocyte count < 100,000/mL
Consider RBC transfusion, independently from hematocrit
values, if
Symptoms of anemia (poor growth, apneas, tachycardia,
heart murmur)
Hypovolemia
Major surgical procedure
Abbreviations: RBC, red blood cell; VLBW, very low birth weight.
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RBC transfusions. All RBC units were collected from repeat
voluntary donors.Whole blood donations were collected into
63mL of citrate phosphate dextrose anticoagulant. RBCswere
obtained by centrifugation at 22  2°C at 1,750 rpm (1,000 g)
for 7 minutes followed by the removal of supernatant plasma
and buffy coat and resuspension in 100mL of saline-adenine-
glucose-mannitol (SAGM) additive solution. Leukocyte reduc-
tion was performed before storage and irradiation immedi-
ately before transfusion. The packed RBCs were transfused
within 5 days of collection in small aliquots of 10 to 20mL/kg,
slowly in 4 hours. None of the patients received erythropoi-
etic drugs in the ﬁrst month of life.
Statistical Analysis
Differences and 95% conﬁdence interval (CI) in the conditions
at birth, morbidity, and outcome within the 28th day of life
between not transfused and transfused neonates were com-
putedwith Pearson chi-square test and Fisher exact test in the
whole group of newborns enrolled and in the ELBW sub-
group. To investigate the role of transfusions in the develop-
ment of the outcomes considered, independently from illness
severity, we introduced a dichotomous variable (comorbid-
ities) which included sepsis, IVH 3 and 4 degrees grade,
mechanical ventilation > 5 days, intubation in the delivery
room, and major surgery in the ﬁrst 14 days. The association
among BW, GA, the presence of at least one comorbidity, and
the number of transfusions performedwithin the 28th day of
life was estimated with a multivariable Poisson regression
model for both transfused and not transfused infants. Results
were expressed as mean and 95% CI. The association between
the composite outcome (death, ROP, BPD, or NEC) and a set of
covariates was estimated with a logistic regression model.
The set included BW, GA, comorbidities (model 1), and
number of transfusions (model 2). The resultswere expressed
as odds ratios (OR) and 95% CI. An analogous model was used
to estimate the association between the occurrence of death,
ROP, or BPD separately considered and the above covariates.
NEC was not considered since it occurred in 15 cases only.
Results
During the study period, 765 VLBW infants were admitted to
our NICU; 124 were excluded because they did not meet the
inclusion criteria. Patients enrolled in the studywere 641, 241
of whom (37.6%) were ELBW infants. Mean GA was 29.4
(standard deviation [SD] ¼ 3) weeks with a mean BW of
1,107 (SD ¼ 303) g. SGA newborns represented 35% of the
entire group. Twins represented 46.8% of the sample. SGA
newborns represented 35% of the entire group. Death oc-
curred in 9% of the sample but in 21% of ELBWpatients. Forty-
two percent of the patients were transfused at least once in
the ﬁrst 28 days of life; this percentage rose to 80.5% for the
ELBW category. Univariate statistical analysis showed that
GA, BW, Apgar score at 1 and 5minutes, need for resuscitation
in the delivery room, mechanical ventilation for more than
5 days, major surgery, incidence of pharmacologically treated
PDA, proven sepsis, length of stay, GMH-IVH grade 3 or 4,
death, BPD, and ROP were signiﬁcantly higher in the trans-
fused group (►Tables 2 and 3); these differences were
conﬁrmed when ELBW infants were analyzed separately.
NEC, with an incidence of 2% in the entire sample, was equally
distributed between the two groups. Twins and SGA new-
borns were more likely not to be transfused in the ﬁrst
28 days. About 80% of ELBW infants transfused developed
at least one of the following comorbidities: sepsis, third and
fourth grades IVH, mechanical ventilation > 5 days, intuba-
tion in the delivery room, major surgery in the ﬁrst 14 days,
compared with 25.5% of neonates not transfused
(p < 0.0001). All ELBW neonates with third and fourth grade
IVH were transfused. ROP developed in 42% of ELBW infants
transfused, compared with 12.7% not transfused
(p < 0.0002); BPD and death occurred more frequently in
transfused ELBW newborns compared with not transfused
(32 vs. 2%, p < 0.0001 and 24 vs. 8.5%, p ¼ 0.018, respective-
ly) (►Table 4). Patients with GA  28 weeks, BW  1,000 g
and with comorbidities had signiﬁcantly higher transfusion
needs, as shown in ►Table 5. Mean pretransfusion hemoglo-
bin was 9.6  1.1 g/dL; mean RBC storage time was 3.1 days.
As shown in►Table 6 (model 1), GA  28weeks, BW  1,000
g, and the presence of comorbidities were all associated with
higher risk of developing the composite outcome considered.
The inclusion of the number of RBC transfusions (model 2)
showed that transfusions inﬂuenced the risk of developing
the composite outcome, both for several transfusions  2
(OR: 3.38; 95% CI: 1.74–6.55) and  3 (OR: 5.88; 95% CI:
2.74–12.6). The risk of developing an adverse outcome
Table 2 Baseline characteristics for continuous variables
Not transfused within 28 d
(no. ¼ 372)
Mean (SD)
95% CI for differences
“not transfused vs. transfused”
Transfused within 28 d
(no. ¼ 269)
Mean (SD)
Birth weight (g) 1,271.2 (197) 353.8; 427.3 880.6 (276)
Gestational age (wk) 31.2 (2.1) 3.9; 4.6 26.9 (2.3)
Apgar 1 (score) 7.0 (1.6) 1.7; 2.26 5.0 (2.1)
Apgar 5 (score) 8.6 (1.1) 0.77; 1.15 7.6 (1.4)
Length of stay (d) 45.0 (15.9)  54.3;  40.9 92.6 (63.2)
Abbreviations: CI, conﬁdence interval; SD, standard deviation.
Note: 95% conﬁdence interval for mean differences not transfused versus transfused. Statistically signiﬁcant differences are in bold.
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ascribable to transfusions was quantiﬁed in 2.5% (difference
between model 2: R2 ¼ 59.0% and model 1: R2 ¼ 56.5%). The
associations between ROP, BPD, and mortality, singly consid-
ered, and the above covariates were shown in►Table 7. None
of the infants who developed NEC during the study period
had been transfused in the 48 hours before the onset of
symptoms.
Discussion
We observed an association between RBC transfusions in the
ﬁrst 28 days of life and the risk of developing the composite
outcome of death, ROP, BPD, or NEC in a cohort of VLBW
infants; transfusions were also associated with ROP grade
 2 and BPD, separately analyzed.We performed a control for
gestational age, BW, and illness severity (i.e., sepsis, GMH-IVH
grade  3, mechanical ventilation for at least 5 days, major
surgery, and intubation in the delivery room), as these
conditions are associated with higher transfusion needs,
and, at the same time, are main determinants for the out-
comes considered. Our data showed a correlation between
outcomes and the number of transfusions performed, inde-
pendently from other variables, and weighted the effect of
transfusions in the development of the outcomes considered.
The association between RBC transfusion and increased
mortality rate was described by dos Santos et al in a cohort
of more than 1,000 VLBW infants; they reported a 1.49 times
higher riskof death in patients transfused in theﬁrstmonth of
life compared with infants who were not, and the risk
increased for those infants transfused more than twice in
the period considered.25 Our study did not conﬁrm this
association; this could be due to the difference in mortality
rates between the two cohorts (9 vs. 27.8%). Another differ-
ence between the two studies is related to transfusion
practices: our patients were transfused according to the
same institutional guidelines, where in the multicenter trial
Table 3 Baseline characteristics for dichotomous variables
Not transfused within
28 d (no. ¼ 372)
No. (%)
95% CI for differences
“not transfused vs. transfused”
Transfused within
28 d (no. ¼ 269)
No. (%)
Twin 182 (48.9)  3.1; 13.2 118 (43.9)
SGA 160 (43.0)  11.7;  26.7 64 (23.8)
PDA 53 (14.3)  56.7;  42.5 172 (63.9)
Major surgery within 28 d 3 (0.8)  19.5;  10.1 42 (15.6)
Intubation in the delivery room 27 (7.3)  51.3;  33. 6 139 (51.7)
Sepsis 12 (3.2)  24.7;  13.6 60 (22.3)
GMH-IVH 3–4 deg grade 1 (0.3)  17.1;  8.4 35 (13.0)
Mechanical ventilation > 5 d 61 (16.4)  62.2;  48.5 193 (71.7)
NEC 5 (1.3)  5.2; 0.5 10 (3.7)
ROP grade  2 19 (5.1)  35.1;  22.3 91 (33.8)
BPD 6 (1.6)  31.3;  19.2 65 (26.9)
Death 5 (1.3)  23.6;  13.1 53 (19.7)
Abbreviations: BPD, bronchopulmonary dysplasia; CI, conﬁdence interval; GMH-IVH, germinal matrix hemorrhage–intraventricular hemorrhage; NEC,
necrotizing enterocolitis; PDA, patent ductus arteriosus; ROP, retinopathy of prematurity; SGA, small for gestational age.
Note: 95% conﬁdence interval for percentage differences “not transfused versus transfused”. Statistically signiﬁcant differences are in bold.
Table 4 Outcomes of ELBW neonates “not transfused” versus “transfused within 28 days of life”
Not transfused within
28 d (no. ¼ 47)
No. (%)
95% CI for differences not
transfused vs. transfused
Transfused within
28 d (no. ¼ 194)
No. (%)
ROP grade  2 6 (12.8)  42.6; 16.4 82 (42.3)
BPD 1 (2.1)  35.1;  17.3 55 (28.3)
GMH-IVH 3–4 deg grade 0 (0)  21.3;  8.6 29 (14.9)
NEC 1 (2.1)  7.1; 5.1 6 (3.1)
Death 4 (8.5)  27.0;  4.4 47 (24.2)
Abbreviations: BPD, bronchopulmonary dysplasia; CI, conﬁdence interval; ELBW, extremely low birth weight; GMH-IVH, germinal matrix hemorrhage–
intraventricular hemorrhage; NEC, necrotizing enterocolitis; ROP, retinopathy of prematurity.
Note: Statistically signiﬁcant differences are in bold.
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by dos Santos et al, RBC transfusions were not standardized
for each center participating in the study. Possible differences
in transfusion practices among hospitals may have affected
the results. In the past years, many observational studies
highlighted a possible temporal association between RBC
transfusion in the neonatal period and the development of
NEC.21–27 Accordingly, we previously described four cases of
transfusion-related NEC, not included in this sample because
they did not meet the inclusion criteria.38 Different hypothe-
ses have been proposed to explain this association: (1)
chronic anemia with a mechanism of hypoperfusion and
reperfusion, (2) enteral nutrition that could reduce mesen-
teric blood ﬂow during RBC transfusion, (3) exposure to
biologically active mediators accumulated during storage,
and (4) impaired gut microcirculation and tissue hypoxia
secondary to prolonged storage that increases RBC adhesion
and depletes erythrocyte nitric oxide. However, none of these
hypotheses has been deﬁnitively conﬁrmed. The present
study did not conﬁrm this association and two recent reports
showed similar results39,40; the lack of association between
Table 6 Composite outcome (death or complications) as a function of GA, BW, comorbidities (model 1) and number of transfusions
(model 2)
Model 1 R2 ¼ 0.5649 Model 2 R2 ¼ 0.5905
Variables OR 95% CI for OR OR 95% CI for OR
GA:  28 vs. > 28 wk 6.61 3.96–11.07 3.69 2.08–6.54
BW:  1,000 vs. > 1,000 g 4.11 2.51–6.74 2.63 1.53–4.52
Comorbidities: yes vs. no 4.30 2.65–6.99 2.97 1.76–4.99
No. of transfusions: 1–2 vs. 0 3.38 1.74–6.55
No. of transfusions:  3 vs. 0 5.88 2.74–12.60
Abbreviations: BW, birth weight; CI, conﬁdence interval; GA, gestational age; OR, odds ratio.
Note: Composite risk of death or complications: at least one among death, retinopathy of prematurity grade  2, bronchopulmonary dysplasia, and
necrotizing enterocolitis. Statistically signiﬁcant differences are in bold.
Table 5 Estimated number of transfusions as a function of GA, BW, and comorbidities (multivariable Poisson model)
Variables Mean no. of transfusions 95% CI for mean
GA  28 wk 2.19 1.96–2.45
GA > 28 wk 0.61 0.52–0.72
BW  1,000 g 2.04 1.83–2.28
BW > 1,000 g 0.66 0.57–0.76
Comorbidities ¼ yes 1.93 1.74–2.14
Comorbidities ¼ no 0.69 0.60–0.80
Abbreviations: BW, birth weight; CI, conﬁdence interval; GA, gestational age.
Note: Comorbidity ¼ yes means the presence of at least one condition among sepsis, intraventricular hemorrhage 3 and 4 degrees grade, mechanical
ventilation > 5 days, intubation in the delivery room, major surgery within 14 days of life. Statistically signiﬁcant differences are in bold.
Table 7 Occurrence of death, ROP, BPD as a function of GA, BW, comorbidities, and number of transfusions
Death
R2 ¼ 0.4026
ROP grade  2
R2 ¼ 0.4187
BPD
R2 ¼ 0.4560
Variables OR 95% CI for OR OR 95% CI for OR OR 95% CI for OR
GA:  28 vs. >28 wk 3.11 1.18–8.21 8.36 3.55–19.68 1.62 0.64–4.07
BW:  1,000 vs. > 1,000 g 5.94 2.31–15.26 1.67 0.86–3.25 1.28 0.55–2.95
Comorbidities: yes vs. no 20.38 4.66–89.16 0.67 0.36–1.25 17.30 5.00–59.86
No. of transfusions: 1–2 vs. 0 0.86 0.75–8.85 1.87 0.73–4.76 1.08 0.32–3.63
No. of transfusions:  3 vs. 0 2.58 0.24–3.17 5.13 1.92–13.67 5.40 1.57–18.63
Abbreviations: BPD, bronchopulmonary dysplasia; BW, birth weight; CI, conﬁdence interval; GA, gestational age; ROP, retinopathy of prematurity.
Note: Statistically signiﬁcant differences are in bold.
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NEC and RBC transfusions in our patients could be related to
the very low incidence of NEC, compared with other studies.
Two recent meta-analysis of observational and randomized
trials have come to different conclusions; the pooled results
from randomized trials supported a correlation between low
RBC transfusion rate and the development of NEC,41 but no
time correlations between transfusion and the development
of NEC were possible. These results contrasted with those
drawn from the meta-analysis of observational studies by
Mohamed and Shah et al24 that conﬁrmed the temporal
correlation between the two events. Recently, a multicenter,
randomized trial34 showed no statistical differences for the
composite risk of NEC, ROP, BPD, GMH-IVH, and death in
newborns with BW  1,250 g randomized to be transfused
with RBC units stored for a mean time of 5.1 days versus
standard issue RBCs (14.6 days), thus excluding a possible role
for standard storage time in the development of complica-
tions of prematurity. GMH-IVH has been recently associated
with early RBC transfusions in neonatal life.28,29 Reactive
oxygen species, endothelial activation, capillary slugging in
the germinal matrix, and increased capillary pressure due to
mechanical or biochemical properties of banked RBC have
been advocated as possible mechanisms of transfusion-relat-
ed GMH-IVH.19 In our study, all ELBW newborns who devel-
oped severe IVHwere transfused in theﬁrst month of life, but
we were not able to investigate a temporal association
between the two events. Delayed cord clamping and umbili-
cal cord milking are well-known procedures to augment
circulating RBC and hemoglobin. Both are associated with a
reduction in the incidence of IVH and NEC.42–44 According to
these observations, that some cases of IVH and NEC are
preceded by a RBC transfusion, one possible mechanism to
explain the beneﬁts derived from placental transfusion is the
reduction in transfusion needs in the ﬁrst week of life.
Recently, a possible role for anemia and RBC transfusion in
the development of ROP has been reported although eviden-
ces are contrasting.12,45,46 Blood transfusions are supposed to
increase the risk of ROP by augmenting retinal oxygen levels;
another pathophysiological mechanism attributed to RBC
transfusion is free iron overload that could contribute to
the production of free oxygen radicals directly responsible
for the damage to the developing retinal vessels.36,47 Our
study supports a signiﬁcant association between ROP grade
 2 and several transfusions higher than two, both in VLBW
and ELBW infants. These data are in agreement with the
hypothesis suggested by Dani et al in a prospective observa-
tional study where they demonstrated that blood transfusion
volume and iron loaded by transfusions increased the risk of
ROP.47 Valieva et al48 did not ﬁnd associations between
volume or number of transfusions and the incidence of ROP
in 60 ELBW patients retrospectively reviewed; however, a
signiﬁcant association with the severity of the disease was
observed. A randomized controlled trial by Brooks et al
comparing 50 newborns with BW  1,250 g transfused
with two transfusion regimes based on hematocrit (< 30
vs. > 40%) failed in demonstrating any association among
hemoglobin, hematocrit, and incidence of ROP,49 but the
small number of patients enrolled may have affected these
results. We found a signiﬁcant association between RBC
transfusion and the development of BPD. This effect correlat-
edwith the number of transfusions performed. Similar results
were reported by Chen et al13 in a randomized trial, where
patients receiving more than 30 mL of RBC in the ﬁrst month
of life resulted to have higher risk of developing BPD, com-
pared with infants treated with a more restrictive regimen. A
possible role for oxidative cellular stress mediated by free
oxygen radicals has been advocated in the physiopathology of
ROP and BPD. Newborns are currently transfused with RBC
from adult donors, where hemoglobin A has lower afﬁnity for
oxygen compared with fetal hemoglobin. Therefore, RBC
transfusion could augment the risk of “oxygen radicals dis-
ease of the newborn” through a “nonphysiologic” oxygen
released to tissues, as recently suggested by Bianchi et al.50
Theoretically, allogeneic umbilical RBC transfusions may play
a protective role in the development of complications associ-
ated with oxidative damages, particularly in the most prema-
ture infants. This intriguing hypothesis should be tested in
future randomized trials. The main limitation of this study is
the introduction of a selection bias related to the fact that
patients transfused are sicker and the outcomes considered
are strongly related to comorbidities; thus, transfusions could
be only a marker for illness severity. However, the variables
related to illness severity were adjusted by using the most
signiﬁcant clinical variables associated with increased trans-
fusion needs, morbidity, and mortality. The logistic regres-
sion model showed that RBC transfusion contributed to the
development of the adverse outcomes considered indepen-
dently from clinical conditions. It is important to point out
that, although signiﬁcant, the contribution of transfusions to
the development of complications of prematurity was
smaller, compared with GA, BW, and the presence of comor-
bidities. In the past years, two randomized trials2,12 that
investigated different transfusion thresholds did not ﬁnd
signiﬁcant associations between number of transfusions
and the development of death, ROP, BPD, and NEC. The study
by Bell et al 12was designed to assess primarily the differences
in transfusion needs between two transfusion thresholds in
100 newbornswith BW less than 1,300 g. Infants in the liberal
group received more RBC transfusions compared with the
restrictive group; the latter showed a higher rate of periven-
tricular leukomalacia and intraparenchymal hemorrhage and
a trend to develop fewer cases of ROP and BPD. The premature
infant in need of transfusion (PINT) trial2 enrolled 451 ELBW
infants to two transfusional regimens to investigate differ-
ences in the composite outcome of death or ROP, BPD, and
NEC. In our opinion, this study did not allow to draw deﬁni-
tive conclusions about the possible correlation between
number of transfusions and outcomes because there were
no statistical differences in the number of transfusions per-
formed between the two arms of the trial. A recent meta-
analysis by Ibrahim et al35 concluded that a restrictive RBC
transfusion threshold resulted in a signiﬁcant lower number
of transfusions and donor exposures and can be usedwithout
incurring in clinically important increase in the risk of death
or major short-term neonatal morbidities. In their review,
Whyte and Kirpalani came to more prudent conclusions51
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suggesting to avoid hemoglobin levels below the lower limits
tested, given the uncertainties of the available data; however,
they state that a restrictive practice does not appear to have a
signiﬁcant impact on death or major morbidities. Long-term
neurodevelopment outcomes from the patients enrolled in
the PINT trial showed some weak evidence of beneﬁts from
the higher hemoglobin threshold group52; conversely, a
statistically signiﬁcant difference in associative verbal ﬂuen-
cy, visualmemory, and reading ability, favoring the restrictive
threshold arm was reported in a subgroup of patients en-
rolled in the IOWA study,53 that was in contrast to the short-
term outcomes from the same group, that showed a lower
rate of brain damage. The effects of transfusion thresholds on
neurocognitive outcome of ELBW (EETNO) trial is ongoing54
and will contribute to clarify the long-term effects of trans-
fusions at different hemoglobin threshold in ELBW infants.
Our study highlights a signiﬁcant association between RBC
transfusions and short-termoutcomes in VLBW infants. There
are some plausible biologic explanations for a contribution of
RBC transfusions to the development of complications of
prematurity. However, it is possible that sicker infants are
more likely to be transfused and therefore prone to develop
complications. The observational nature of our study could
not elucidate the eventual cause–effect relationships and
large randomized trials are required to conﬁrm the possible
detrimental role of RBC transfusions in premature infants.
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